Prandial Metabolic Phenotype in Adults

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60-80
SponsorTexas A&M University

About this trial

Previous studies suggest that changes in metabolism due to the effects of aging might serve as a potential for therapeutic agents. The investigating lab developed a pulse method combining multiple stable isotopes to study multiple metabolic pathways in the same individual simultaneously. By measuring whole-body metabolism in a large group of older adults, the investigators may be able to unravel age-related deterioration in protein turnover (synthesis and breakdown) that contributes to impaired functional capacity. Metabolic profiles could explain differences in pathways in the aging process with special interest in metabolism of amino acids as they have been associated with aging-related disorders.

Eligibility criteria

Qualifiers

Age: 60-80, inclusive

Stable body-weight (± 5%) for the past 3 months

Subject is judged to be in satisfactory health based on medical history, physical examination, and laboratory screening evaluations.

Ability to walk, sit down and stand up independently or with walking mobility aids

Disqualifiers

Established diagnosis of current malignancy

History of untreated metabolic diseases including hepatic or renal disorder

Presence of acute illness or metabolically unstable chronic illness

Presence of fever within the last 3 days

Trial design

Treatments tested in this trial

  • Total Amino Acids
  • Essential Amino Acids
  • Essential Amino Acids + Hydroxy-methylbutyric acid (HMB)
  • Essential Amino Acids + Leucine
  • Essential Amino Acids High
  • Placebo Water

Treatment groups

50 Participants
are divided into 2 treatment groups

Sponsors and collaborators